Want to join the conversation?
$MDGN said it has entered into a collaboration with Kyowa Hakko Kirin for the development and commercialization of Kyowa's first-in-class anti-LIGHT monoclonal antibody. The anti-LIGHT monoclonal antibody is a Phase 2-ready biologic with available clinical supply.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!